ArticleBMC genomic data2026
Genetic polymorphism of SNPs rs9399137 and rs4895441in HBS1L-MYB and SNP rs766432 in BCL11A among β-thalassemia Egyptian patients.
Article in BMC genomic data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to evaluate the role of two genetic polymorphisms (rs9399137 and rs4895441) in the HBS1L-MYB and rs766432 of BCL11A genes as determinant HbF level and disease severity in Egyptian β-thalassemia patients.
methodsBlood samples were obtained from 100 participants, comprising 50 individuals with β-thalassemia and 50 healthy controls. Hematological assessment was conducted through complete blood count (CBC), ferritin measurement, and hemoglobin electrophoresis. After genomic DNA extraction was done, HBS1L-MYB (rs9399137 and rs4895441) SNPs and rs766432 of BCL11A were all assessed by ARMS-PCR .The HBS1L-MYB rs4895441 assessed by RFLP-PCR with the restriction enzyme (RSA1).
resultsThe genotypic frequencies of the rs766432 SNP of BCL11A and rs9399137 indicated that the genotype frequencies of these SNPs were significantly associated with severity of β thalassemia but there was no significant association between β-thalassemia severity and rs895441 SNP of HSB1L-MYB.
conclusionsIn Egyptian β-thalassemia patients, rs766432 in BCL11A and rs9399137 in HBSIL-MYB were found to significantly increase HbF levels, but rs4895441 was not. New tailored management techniques to decrease transfusion needs can be developed based on these findings, which show how genetic and clinical factors affect the severity of β-thalassemia. Further research involving a larger sample size and additional modifier genes is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.